February 8, 2025 Week in Review: Trade Wars, Earnings, and Labor Data
February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
Amazon: Slowing Growth Highlights Valuation Risks for Investors
Tesla and Lucid: Strategic Insights for a Long/Short Position
Apple: Resilient Growth and Strategic Innovation Bolster Confidence
Nvidia's Growth Backed by Hyperscaler Spending and AI Industry Momentum
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
Foghorn Therapeutics (FHTX) stock forecast for 2026
Updated: February 16, 2025 (21:36)
Sector: HealthcareThe share price of Foghorn Therapeutics Inc. (FHTX) now
50/200 Day Moving Average: $5.0 / $6.54
This figure corresponds to the Average Price over the previous 50/200 days. For Foghorn Therapeutics stocks, the 50-day moving average is the resistance level today.
For Foghorn Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Foghorn Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Foghorn Therapeutics stock price in 2026. How much will one Foghorn Therapeutics share be worth in 2026? Is it worth taking profit / loss on FHTX stock now or waiting? What are analysts' forecasts for Foghorn Therapeutics stock?
We forecast Foghorn Therapeutics stock performance using neural networks based on historical data on FHTX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Foghorn Therapeutics Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Foghorn Therapeutics analysts is $11.71. Today 200 Day Moving Average is the resistance level (6.54 $). 50 Day Moving Average is the resistance level (5.0 $).
Historical and forecast chart of Foghorn Therapeutics Inc. stock
The chart below shows the historical price of Foghorn Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the FHTX stock price can be found in the table below.
Foghorn Therapeutics Inc. focuses on the discovery and development of drugs targeting genetically determined addictions in the chromatin regulatory system. The Company’s gene traffic management platform enables it to identify, validate and potentially use drug targets in the chromatin regulatory system. It is initially focused on oncology. The company is developing FHD-286, a selective allosteric ATPase inhibitor, and FHD-609, a protein breaker, for the treatment of hematologic cancers and solid tumors. FHD-286 is an allosteric and orally available, small molecule, enzymatic inhibitor of BRG1 and BRM, which is initially being developed for the treatment of acute myeloid leukemia (AML) and uveal melanoma. FHD-609 is an intravenous, small molecule protein breaker BRD9. The company is also developing complementary programs for large populations, which include selective BRM and selective ARID1B modulators.
Foghorn Therapeutics (FHTX) Forecast for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 2.70 | 1.75 | 3.12 | 43.94 % |
Feb | 1.66 | 1.08 | 2.23 | 51.44 % |
Mar | 1.68 | 1.31 | 2.29 | 42.99 % |
Apr | 2.07 | 1.67 | 2.38 | 29.82 % |
May | 2.88 | 1.79 | 3.46 | 48.09 % |
Jun | 3.11 | 2.30 | 4.04 | 43.00 % |
Jul | 2.54 | 2.17 | 3.26 | 33.61 % |
Aug | 3.57 | 2.47 | 4.90 | 49.70 % |
Sep | 4.95 | 3.28 | 6.00 | 45.39 % |
Oct | 2.93 | 2.29 | 3.33 | 31.02 % |
Nov | 2.67 | 2.35 | 3.04 | 22.66 % |
Dec | 2.98 | 2.25 | 3.59 | 37.39 % |
Foghorn Therapeutics information and performance
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US
Market capitalization of the Foghorn Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FHTX shares in the company outstanding by the market price of one share.
EBITDA of Foghorn Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Foghorn Therapeutics price target for 2026 by month
Target values for the price of one Foghorn Therapeutics share for Jan 2026.
In Jan, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 43.944% volatility is expected.
Pessimistic target level: 1.75
Optimistic target level: 3.12
Target values for the price of one Foghorn Therapeutics share for Feb 2026.
In Feb, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 51.441% volatility is expected.
Pessimistic target level: 1.08
Optimistic target level: 2.23
Target values for the price of one Foghorn Therapeutics share for Mar 2026.
In Mar, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 42.990% volatility is expected.
Pessimistic target level: 1.31
Optimistic target level: 2.29
Target values for the price of one Foghorn Therapeutics share for Apr 2026.
In Apr, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 29.824% volatility is expected.
Pessimistic target level: 1.67
Optimistic target level: 2.38
Target values for the price of one Foghorn Therapeutics share for May 2026.
In May, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 48.091% volatility is expected.
Pessimistic target level: 1.79
Optimistic target level: 3.46
Target values for the price of one Foghorn Therapeutics share for Jun 2026.
In Jun, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 42.997% volatility is expected.
Pessimistic target level: 2.30
Optimistic target level: 4.04
Target values for the price of one Foghorn Therapeutics share for Jul 2026.
In Jul, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 33.605% volatility is expected.
Pessimistic target level: 2.17
Optimistic target level: 3.26
Target values for the price of one Foghorn Therapeutics share for Aug 2026.
In Aug, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 49.697% volatility is expected.
Pessimistic target level: 2.47
Optimistic target level: 4.90
Target values for the price of one Foghorn Therapeutics share for Sep 2026.
In Sep, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 45.390% volatility is expected.
Pessimistic target level: 3.28
Optimistic target level: 6.00
Target values for the price of one Foghorn Therapeutics share for Oct 2026.
In Oct, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 31.022% volatility is expected.
Pessimistic target level: 2.29
Optimistic target level: 3.33
Target values for the price of one Foghorn Therapeutics share for Nov 2026.
In Nov, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 22.655% volatility is expected.
Pessimistic target level: 2.35
Optimistic target level: 3.04
Target values for the price of one Foghorn Therapeutics share for Dec 2026.
In Dec, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 37.388% volatility is expected.
Pessimistic target level: 2.25
Optimistic target level: 3.59
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.